B J Gurley

Summary

Affiliation: University of Arkansas for Medical Sciences
Country: USA

Publications

  1. ncbi Content versus label claims in ephedra-containing dietary supplements
    B J Gurley
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Am J Health Syst Pharm 57:963-9. 2000
  2. ncbi Drug interaction between St. John's wort and cyclosporine
    G W Barone
    Department of Surgery, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Ann Pharmacother 34:1013-6. 2000
  3. ncbi Herbal supplements: a potential for drug interactions in transplant recipients
    G W Barone
    Department of Surgery, Pharmaceutical Sciences, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Transplantation 71:239-41. 2001
  4. ncbi The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria
    G W Barone
    Department of Surgery Slot 520-4, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, USA
    J Clin Pharmacol 41:113-5. 2001
  5. ncbi St John's wort: a hidden risk for transplant patients
    S M Turton-Weeks
    University of Arkansas for Medical Sciences, Little Rock, Ark, USA
    Prog Transplant 11:116-20. 2001
  6. ncbi Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo
    B J Gurley
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
    Clin Pharmacol Ther 83:61-9. 2008
  7. ncbi Effect of interleukin 6 on the hepatic metabolism of itraconazole and its metabolite hydroxyitraconazole using primary human hepatocytes
    P O Gubbins
    Department of Pharmacy Practice, College of Pharmacy, University of Arkansas for Medical Sciences, 4301 W Markham, Slot 522, Little Rock, AR 7225 7122, USA
    Pharmacology 67:195-201. 2003

Collaborators

Detail Information

Publications7

  1. ncbi Content versus label claims in ephedra-containing dietary supplements
    B J Gurley
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Am J Health Syst Pharm 57:963-9. 2000
    ..One product was devoid of ephedra alkaloids. Assay of 20 ephedra-containing dietary supplements showed that alkaloid content often differed markedly from label claims and was inconsistent between two lots of some products...
  2. ncbi Drug interaction between St. John's wort and cyclosporine
    G W Barone
    Department of Surgery, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Ann Pharmacother 34:1013-6. 2000
    ..To report a probable drug interaction between the herbal dietary supplement St. John's wort and cyclosporine...
  3. ncbi Herbal supplements: a potential for drug interactions in transplant recipients
    G W Barone
    Department of Surgery, Pharmaceutical Sciences, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Transplantation 71:239-41. 2001
    ..Potential herb-prescription drug interactions are not just limited to SJW. Inquiries regarding the usage of herbal supplements should be an integral component of a transplant recipient's medication history...
  4. ncbi The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria
    G W Barone
    Department of Surgery Slot 520-4, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, USA
    J Clin Pharmacol 41:113-5. 2001
    ..This patient's pretransplant evaluation also suggested that cyclosporine may be safe for some patients with acute intermittent porphyria...
  5. ncbi St John's wort: a hidden risk for transplant patients
    S M Turton-Weeks
    University of Arkansas for Medical Sciences, Little Rock, Ark, USA
    Prog Transplant 11:116-20. 2001
    ..Transplant coordinators are in a critical position to educate transplant recipients about the potential risks of herbal medication usage...
  6. ncbi Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo
    B J Gurley
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
    Clin Pharmacol Ther 83:61-9. 2008
    ..6+/-26.9 vs 71.2+/-50.5 ng/ml). MDZ disposition was not affected by kava kava supplementation. These findings suggest that significant herb-drug interactions may result from the concomitant ingestion of goldenseal and CYP3A substrates...
  7. ncbi Effect of interleukin 6 on the hepatic metabolism of itraconazole and its metabolite hydroxyitraconazole using primary human hepatocytes
    P O Gubbins
    Department of Pharmacy Practice, College of Pharmacy, University of Arkansas for Medical Sciences, 4301 W Markham, Slot 522, Little Rock, AR 7225 7122, USA
    Pharmacology 67:195-201. 2003
    ..Human hepatocytes in primary culture can metabolize ITZ. However, IL-6 did not inhibit hydroxyitraconazole formation, but it may inhibit its subsequent metabolism...